PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas

被引：0
|
作者：
Black, J. D. [1 ]
Lopez, S. [1 ]
Cocco, E. [1 ]
Bellone, S. [1 ]
Altwerger, G. [1 ]
Schwab, C. L. [1 ]
English, D. P. [1 ]
Bonazzoli, E. [1 ]
Predolini, F. [1 ]
Ferrari, F. [1 ]
Ratner, E. [1 ]
Silasi, D. A. [1 ]
Azodi, M. [1 ]
Schwartz, P. E. [1 ]
Santin, A. D. [1 ]
机构：
[1] Yale Univ, New Haven, CT 06520 USA
来源：
GYNECOLOGIC ONCOLOGY | 2015年 / 139卷 / 03期
关键词：
D O I：
10.1016/j.ygyno.2015.09.058
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：596 / 596
页数：1
相关论文
共 50 条
  • [41] Dual CCNE1/PIK3CA targeting is synergistic in CCNE1-amplified/PIK3CA-mutated uterine serous carcinomas in vitro and in vivo
    Emiliano Cocco
    Salvatore Lopez
    Jonathan Black
    Stefania Bellone
    Elena Bonazzoli
    Federica Predolini
    Francesca Ferrari
    Carlton L Schwab
    Gulden Menderes
    Luca Zammataro
    Natalia Buza
    Pei Hui
    Serena Wong
    Siming Zhao
    Yalai Bai
    David L Rimm
    Elena Ratner
    Babak Litkouhi
    Dan-Arin Silasi
    Masoud Azodi
    Peter E Schwartz
    Alessandro D Santin
    British Journal of Cancer, 2016, 115 : 303 - 311
  • [42] Dual CCNE1/PIK3CA targeting is synergistic in CCNE1-amplified/PIK3CA-mutated uterine serous carcinomas in vitro and in vivo
    Cocco, Emiliano
    Lopez, Salvatore
    Black, Jonathan
    Bellone, Stefania
    Bonazzoli, Elena
    Predolini, Federica
    Ferrari, Francesca
    Schwab, Carlton L.
    Menderes, Gulden
    Zammataro, Luca
    Buza, Natalia
    Hui, Pei
    Wong, Serena
    Zhao, Siming
    Bai, Yalai
    Rimm, David L.
    Ratner, Elena
    Litkouhi, Babak
    Silasi, Dan-Arin
    Azodi, Masoud
    Schwartz, Peter E.
    Santin, Alessandro D.
    BRITISH JOURNAL OF CANCER, 2016, 115 (03) : 303 - 311
  • [43] Cooperative oncogenic effect and cell signaling crosstalk of co-occurring HER2 and mutant PIK3CA in mammary epithelial cells
    Dong, Lun
    Meng, Fanyan
    Wu, Ling
    Mitchell, Allison V.
    Block, C. James
    Zhang, Bin
    Craig, Douglas B.
    Jang, Hyejeong
    Chen, Wei
    Yang, Qifeng
    Wu, Guojun
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2017, 51 (04) : 1320 - 1330
  • [44] Overexpression of PIK3CA impacts global survival of patients with HER2 subtype breast carcinoma
    Felicidade, Sidnei Iensen
    Salles Pilar, Emily Ferreira
    Flores Texeira, Joara Predebom
    Watte, Guilherme
    Remonatto, Gabriela
    Sant'Anna Alves, Rita de Cassia
    Roehe, Adriana Vial
    JOURNAL OF BUON, 2020, 25 (06): : 2546 - 2551
  • [45] PIK3CA and EGFR mutation in triple negative breast carcinoma: Comparison with hormone receptors positive and HER2 positive breast carcinomas
    Pestereli, H. E.
    Ozcan, M.
    Erdogan, G.
    Karaveli, F. S.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 248 - 248
  • [46] Trastuzumab Response in Iraqi Women with Her2 Positive Breast Cancer: The Role of PIK3CA Oncogene Mutations at E542k and E545k
    Hammadi, Alyaa H.
    Ali, Shatha H.
    MEDICINA BALEAR, 2024, 39 (02):
  • [47] PIK3CA Mutations Are Associated With Lower Rates of Pathologic Complete Response to Anti-Human Epidermal Growth Factor Receptor 2 (HER2) Therapy in Primary HER2-Overexpressing Breast Cancer
    Loibl, Sibylle
    von Minckwitz, Gunter
    Schneeweiss, Andreas
    Paepke, Stefan
    Lehmann, Annika
    Rezai, Mahdi
    Zahm, Dirk M.
    Sinn, Peter
    Khandan, Fariba
    Eidtmann, Holger
    Dohnal, Karel
    Heinrichs, Clemens
    Huober, Jens
    Pfitzner, Berit
    Fasching, Peter A.
    Andre, Fabrice
    Lindner, Judith L.
    Sotiriou, Christos
    Dykgers, August
    Guo, Sanxing
    Gade, Stephan
    Nekljudova, Valentina
    Loi, Sherene
    Untch, Michael
    Denkert, Carsten
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (29) : 3212 - 3220
  • [48] A retrospective study evaluating the effect of trastuzumab addition to carboplatin/paclitaxel on overall survival in patients with advanced-stage HER2/neu-overexpressing uterine serous carcinoma or carcinosarcoma
    Lu, Ting-Fang
    Sun, Lou
    Shih, Yu-Hsiang
    Chen, Yen-Fu
    Fan, Chun-Ting
    Wang, Shao-Jing
    Hsu, Shih-Tien
    Liu, Chih-Ku
    Hwang, Sheau-Feng
    Lu, Chien-Hsing
    BMC MEDICINE, 2025, 23 (01):
  • [49] Analysis of PIK3CA mutation abundance in primary breast cancer with droplet digital PCR identifies frequent sub-clonal PIK3CA mutations in ER negative and/or HER2 positive breast cancer
    Garcia-Murillas, I.
    Pearson, A.
    Lambros, M.
    Natrajan, R.
    Segal, C.
    Dowsett, M.
    Turner, N. C.
    CANCER RESEARCH, 2013, 73
  • [50] Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms
    Nakayama, Kentaro
    Nakayama, Naomi
    Kurman, Robert L.
    Cope, Leslie
    Pohl, Gudrun
    Samuels, Yardena
    Velculescu, Victor E.
    Wang, Tian-Li
    Shih, le-Ming
    CANCER BIOLOGY & THERAPY, 2006, 5 (07) : 779 - 785
12345